116 related articles for article (PubMed ID: 31531437)
1. A non-cationic nucleic acid nanogel for the delivery of the CRISPR/Cas9 gene editing tool.
Ding F; Huang X; Gao X; Xie M; Pan G; Li Q; Song J; Zhu X; Zhang C
Nanoscale; 2019 Oct; 11(37):17211-17215. PubMed ID: 31531437
[TBL] [Abstract][Full Text] [Related]
2. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
3. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
4. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
5. A Crosslinked Nucleic Acid Nanogel for Effective siRNA Delivery and Antitumor Therapy.
Ding F; Mou Q; Ma Y; Pan G; Guo Y; Tong G; Choi CHJ; Zhu X; Zhang C
Angew Chem Int Ed Engl; 2018 Mar; 57(12):3064-3068. PubMed ID: 29364558
[TBL] [Abstract][Full Text] [Related]
6. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
8. Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.
Tang Q; Liu J; Jiang Y; Zhang M; Mao L; Wang M
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46585-46590. PubMed ID: 31763806
[TBL] [Abstract][Full Text] [Related]
9. Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
Wang HX; Song Z; Lao YH; Xu X; Gong J; Cheng D; Chakraborty S; Park JS; Li M; Huang D; Yin L; Cheng J; Leong KW
Proc Natl Acad Sci U S A; 2018 May; 115(19):4903-4908. PubMed ID: 29686087
[TBL] [Abstract][Full Text] [Related]
10. Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing.
Liu BY; He XY; Xu C; Ren XH; Zhuo RX; Cheng SX
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23870-23879. PubMed ID: 31257851
[TBL] [Abstract][Full Text] [Related]
11. Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes.
Jain PK; Lo JH; Rananaware S; Downing M; Panda A; Tai M; Raghavan S; Fleming HE; Bhatia SN
Nanoscale; 2019 Nov; 11(44):21317-21323. PubMed ID: 31670340
[TBL] [Abstract][Full Text] [Related]
12. Versatile Redox-Responsive Polyplexes for the Delivery of Plasmid DNA, Messenger RNA, and CRISPR-Cas9 Genome-Editing Machinery.
Wang Y; Ma B; Abdeen AA; Chen G; Xie R; Saha K; Gong S
ACS Appl Mater Interfaces; 2018 Sep; 10(38):31915-31927. PubMed ID: 30222305
[TBL] [Abstract][Full Text] [Related]
13. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
Altenbuchner J
Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
[TBL] [Abstract][Full Text] [Related]
14. Efficient genome editing by CRISPR/Cas9 with a tRNA-sgRNA fusion in the methylotrophic yeast Ogataea polymorpha.
Numamoto M; Maekawa H; Kaneko Y
J Biosci Bioeng; 2017 Nov; 124(5):487-492. PubMed ID: 28666889
[TBL] [Abstract][Full Text] [Related]
15. Temperature effect on CRISPR-Cas9 mediated genome editing.
Xiang G; Zhang X; An C; Cheng C; Wang H
J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool.
Sahel DK; Mittal A; Chitkara D
J Pharmacol Exp Ther; 2019 Sep; 370(3):725-735. PubMed ID: 31122933
[TBL] [Abstract][Full Text] [Related]
17. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
18. The CRISPR/Cas9 system and its applications in crop genome editing.
Bao A; Burritt DJ; Chen H; Zhou X; Cao D; Tran LP
Crit Rev Biotechnol; 2019 May; 39(3):321-336. PubMed ID: 30646772
[TBL] [Abstract][Full Text] [Related]
19. Dramatic Improvement of CRISPR/Cas9 Editing in
Ng H; Dean N
mSphere; 2017; 2(2):. PubMed ID: 28435892
[TBL] [Abstract][Full Text] [Related]
20. Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems.
Mao Y; Yang X; Zhou Y; Zhang Z; Botella JR; Zhu JK
Genome Biol; 2018 Sep; 19(1):149. PubMed ID: 30266091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]